Market Overview

UPDATE: UBS Securities Downgrades Calpine on Concerns About Texas and California

Share:
Related CPN
Calpine Q1 Loss Widens, Reaffirms Full Year EBITDA Forecast
Earnings Scheduled For April 29, 2016
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2016 Update (Seeking Alpha)

In a report published Wednesday, UBS Securities analyst Julien Dumoulin-Smith downgraded the rating on Calpine (NYSE: CPN) from Buy to Neutral, but reiterated the $22.00 price target.

In the report, UBS Securities noted, “We're downgrading shares to Neutral from Buy following its latest move, and our concerns around TX (Guadalupe being potentially dilutive to '15 multiple) and CA. While developments in the Northeast are constructive, we see its more limited footprint and exposure to upcoming PJM capacity auction in (E)MAAC as less than ideal.”

Calpine closed on Tuesday at $20.44.

Latest Ratings for CPN

DateFirmActionFromTo
May 2016SunTrust Robinson HumphreyMaintainsNeutral
Mar 2016CitigroupMaintainsBuy
Mar 2016Argus ResearchDowngradesBuyHold

View More Analyst Ratings for CPN
View the Latest Analyst Ratings

Posted-In: Julien Dumoulin-Smith UBS SecuritiesAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CPN)

View Comments and Join the Discussion!